S. Senda, H. Izumi, and H. Fujimura, “On uracil deriva- tives and related compounds. 6, 5-alkyl-2,4,6-trioxo-per- hydrophyrimidine derivatives as antiphlogistics,” Arznei- mittelforschung; vol. 17, no.12, December 1967, pp. 1519-1523.
 N. Takamura , T. maruyama, E. Chosa, K. Kawai, Y. Tsutsumi, Y. Uryu, K. Yamasaki, T. Deguchi, and M. Otagiri, “Bucolome, a potent binding inhibitor for fu- rosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome,” Drug Metabo- lism and Disposition,vol. 33, no. 4, April 2005, pp. 596- 602.
 M. Osawa, N. Hada, K. Matsumoto, T. Hasegawa, D. Kobayashi, Y. Morimoto, M. Yamaguchi, I. Kanamoto, T. Nakagawa, and K. Sugibayashi, “Usefulness of coadmin- istration of bucolome in warfarin therapy: pharmacoki- netic and pharmacodynamic analysis using outpatient prescriptions,” Internal Journal of Pharmaceutics, vol. 293, no. 1-2, April 2005, pp. 43-49.
 M. Kobayashi, M. Takagi, K. Fukumoto, R. Kato, K. Tanaka, and K.Ueno, “The effect of bucolome, a CYP2C9 inhibitor, on the pharmacokinetics of losartan,” Drug Metabolism and Disposition, vol. 23, no. 2, 2008, pp. 115-119.
 S. M. Neighbors, and W. H. Soine, “Identification of Phenobarbital N-glucuronides as urinary metabolites of Phenobarbital in mice,” Drug Metabolism and Disposi- tion, vol. 23, no. 5, May, 1995, pp. 548-552.
 K. Mohri, T. Uesugi, and K. Kamisaka, “Bucolome N- glucuronide: purification and identification of a major metabolite of bucolome in rat bile,” Xenobiotica, vol. 15, no. 7, July, 1985, pp. 615-621.
 K. Mohri, and Y. Uesawa, “Enzymatic Activities in the Microsomes Prepareted from Rat Small Intestinal Epithelial Cells by Differential Procedures,” Pharmaceutical Research, vol. 18, no. 8, Augasut, 2001, pp. 1232-1236.
 P. K. Smith, R. I. Krohn, G.T. Hermanson, A. K. Malliam F. H. Garther, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk, “Measurement of protein using bicinchoninic acid,” Analitycal Biochemistry, vol. 150, no. 1, October, 1985, pp. 76-85.
 S. Ikushiro, M. Sahara, Y. Emi, Y. Yabusaki, and T. Iya- nagi, “Functional Coexpression of Xenobiotic Metabo- lizing Enzymes, Rat Cytochrome P4501A1 and UDP- Glucuronosyltransferase 1A6, in Yeast Microsomes,” Bio- chimica et Biophysica Acta , vol. 1672, 2004, pp. 86-92.
 T. Iyanagi, M. Haniu, K. Sogawa, Y. Fujii-Kuriyama, S. Watanabe, J. E. Shively, and K. F. Anan, “Cloning and characterization of cDNA encoding 3-methylcholanthre- ne inducible rat mRNA for UDP-glucuronosyltransfer- ase,” Journal of Biological Chemistry, vol. 261, no. 33, November, 1986, pp. 15607-15614.
 T. Iyanagi, “Molecular basis of multiple UDP-glucurono- syltransferase isoenzyme deficiencies in the hyperbiliru- binemic rat (Gunn rat),” Journal of Biological Chemistry, vol. 266, no. 35, December, 1991, pp. 24048-24052.
 Y. Emi, S. Ikushiro, and Y. Kato, “Thyroxine-metabo- lizing Rat UDP-glucuronosyltransferase 1A7 is Regulated by Thyroid Hormone Receptor,” Endocrinology, vol. 148, no. 12, December, 2007, pp. 6124-6133.
 S. Ikushiro, Y. Emi, and T. Iyanagi, “Identification and analysis of drug-responsive expression of UDP-glu- curonosyltransferase family 1 (UGT1) isozymes in rat hepatic microsomes using anti-peptide antibodies,” Ar- chives of Biochemistry and Biophysics, vol, 324, no. 2, December, 1995, pp. 267-272.
 N. Kasai, T. Sakai, R. Shinkyo, S. Ikushiro, T. Iyanagi, M. Kamao, T, Okano, and K. Inoue, “Sequential Metabolism of 2,3,7-Trichlorodibenzo-p-dioxin (2,3,7-triCDD) by Cytochrome P450 and UDP-Glucuronosyltransferase in Human Liver Microsomes,” Drug Metabolism and Dis- position, vol. 32, no. 8, August, 2004, pp. 870-875.
 K. Mohri, Y. Uesawa, and T. Uesugi, “Metabolisme of bucolome in rats. Stability and biliary excretion of buco- lome N-glucuronide,” Journal of Chromatogrphy B, vol. 759, no. 1, August, 2001, pp. 153-159.
 N. R. Vansell, and C. D. Klaassen, “Increase in rat liver UDP-glucuronosyltransferase mRNA by microsomal en- zyme inducers that enhance thyroid hormone glucuroni- dation,” Drug Metabolism and Disposition, vol, 30, no.3, March, 2002, pp. 240-246.
 M. K. Shelby, N.J. Cherrington, N. R. Vansell, and C. D. Klaassen, “Tissue mRNA Expression of the Rat UDP- Glucuronosyltransferase Gene Family,” Drug Metabolism and Disposition, vol. 31, no. 3, March, 2003, pp. 326- 333.
 J. R. Chowdhury, R. Kondapalli, and N. R. Chowdhury, “Gunn rat: A model for inherited deficiency of bilirubin glucuronidation,” Advances in Veterinary Science and Comparative Medicine, vol. 37, 1993, pp. 149-173.
 H. Kanoh, K. Okada, and K. Mohri, “Identification of the UDP-glucuronosyltransferase responsible for bucolome N-glucuronide formation in rats,” Pharmazie, vol. 65, no. 11, November, 2010, pp. 840-844.